Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics

PHASE3CompletedINTERVENTIONAL
Enrollment

769

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Schizophrenia
Interventions
DRUG

paliperidone palmitate injection

injection with 150 mg equivalent on Day 1, 100 mg equivalent on Day 8, 75 mg equivalent on Day 38 and flexible dosing with 25, 50, 75, 100 or 150 mg equivalent once monthly thereafter

DRUG

oral antipsychotics

daily treatment according to local label for maximally 24 months

Trial Locations (94)

Unknown

Vienna

Bertrix

Ghent

Liège

Ostend

Burgas

Plovdiv

Radnevo

Zagreb

Brno

Litoměřice

Olomouc

Prague

Přerov

Alexandria

Cairo

Talinn

Tartu

Colombes

La Seyne-sur-Mer

Limoges

Metz

Paris

Saint-Avé

Berlin

Bochum

Mannheim

München

Thessalonikis

Budapest

Kalocsa

Nagykálló

Sopron

Bat Yam

Beer Yaakov

Hod HaSharon

Ramat Gan

Tirat Hacarmel

Amman

Šiauliai

Vilnius

Chełmno

Gdansk

Torun

Ząbki

Arad

Bucharest

Jebel

Oradea

Sibiu

Ekaterinburg Na

Krasnodar

Nizny Novgorod

Saint Petersburg

Samara

Saratov

Tomsk

Yaroslavl

Bratislava

Michalovce

Rimavská Sobota

Cape Town

Pretoria

Goyang

Incheon

Kyounggi

Seoul

Barcelona

Burgos

Elche

Madrid

Sant Boi de Llobregat

Zamora

Taichung

Taipei

Taoyuan District

Istanbul

Manisa Turkey

Zonguldak

Dnipropetrovsk

Donetsk

Hlevakha

Kharkiv

Kherson

Kiev

Lviv

Odesa

Poltava

Simferopol

Uzhhorod

Birmingham

Exeter

London

Warrington

Sponsors
All Listed Sponsors
lead

Janssen-Cilag International NV

INDUSTRY